Abstract
Monoclonal antibody (mAb) MN423 recognizes Alzheimers disease specific conformation of tau protein assembled into paired helical filaments (PHF). Since the three-dimensional structure of PHF is currently unavailable, the structure of MN423 binding site could provide important information about PHF conformation with the consequences for the Alzheimers disease prevention and cure. Fab fragment of MN423 was prepared and purified. We have identified two different conditions for crystallization of the Fab fragment that yielded two crystal forms. They diffracted to 3.0 and 1.6 Å resolution with four and one molecule in the asymmetric unit, respectively. Both crystal forms belonged to the space group P21 with unit cell parameters a = 76.4 Å, b = 138.4 Å, c = 92.4 Å, β = 101.9∞, and a = 71.5 Å, b = 36.8 Å, c = 85.5 Å , β = 113.9∞.
Keywords: Alzheimer's disease, Paired Helical Filaments, Fab fragment, Crystallization, X-ray data
Protein & Peptide Letters
Title: Preparation, Crystallization and Preliminary X-Ray Analysis of the Fab Fragment of Monoclonal Antibody MN423, Revealing the Structural Aspects of Alzheimers Paired Helical Filaments
Volume: 13 Issue: 9
Author(s): Natalia Csokova, Rostislav Skrabana, L'ubica Urbanikova, Branislav Kovacech, Alexander Popov, Jozef Sevcik and Michal Novak
Affiliation:
Keywords: Alzheimer's disease, Paired Helical Filaments, Fab fragment, Crystallization, X-ray data
Abstract: Monoclonal antibody (mAb) MN423 recognizes Alzheimers disease specific conformation of tau protein assembled into paired helical filaments (PHF). Since the three-dimensional structure of PHF is currently unavailable, the structure of MN423 binding site could provide important information about PHF conformation with the consequences for the Alzheimers disease prevention and cure. Fab fragment of MN423 was prepared and purified. We have identified two different conditions for crystallization of the Fab fragment that yielded two crystal forms. They diffracted to 3.0 and 1.6 Å resolution with four and one molecule in the asymmetric unit, respectively. Both crystal forms belonged to the space group P21 with unit cell parameters a = 76.4 Å, b = 138.4 Å, c = 92.4 Å, β = 101.9∞, and a = 71.5 Å, b = 36.8 Å, c = 85.5 Å , β = 113.9∞.
Export Options
About this article
Cite this article as:
Csokova Natalia, Skrabana Rostislav, Urbanikova L'ubica, Kovacech Branislav, Popov Alexander, Sevcik Jozef and Novak Michal, Preparation, Crystallization and Preliminary X-Ray Analysis of the Fab Fragment of Monoclonal Antibody MN423, Revealing the Structural Aspects of Alzheimers Paired Helical Filaments, Protein & Peptide Letters 2006; 13 (9) . https://dx.doi.org/10.2174/092986606778256180
DOI https://dx.doi.org/10.2174/092986606778256180 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Proteomic Approaches to Study the Pig Intestinal System
Current Protein & Peptide Science Genistein: A Boon for Mitigating Ischemic Stroke
Current Topics in Medicinal Chemistry Preface [Hot topic: Autoimmunity (Executive Editors: D. Stahl and W. Sibrowski)]
Current Pharmaceutical Design Synaptic Elimination in Neurological Disorders
Current Neuropharmacology Cancer-related Fatigue, Inflammation and Thyrotropin-releasing Hormone
Current Aging Science Child Abuse and Neglect and its Psycho-Physical and Social Consequences: A Review of the Literature
Current Pediatric Reviews Mechanisms of Action of DNA-Damaging Anticancer Drugs in Treatment of Carcinomas: Is Acute Apoptosis an “Off-Target” Effect?
Mini-Reviews in Medicinal Chemistry Neurobiological Mechanisms of Stress Resilience and Implications for the Aged Population
Current Neuropharmacology The Role of Intravenous Dihydropyridine Calcium Channel Blockers in the Perioperative Management of Patients Undergoing Coronary Artery Bypass Surgery
Current Vascular Pharmacology Current Targets for Anticancer Drug Discovery
Current Drug Targets Editorial (Thematic Issue: Molecular and Cellular Engineering Approaches for Neurological Disorders, Diseases, and Injuries Involved the Central and Peripheral Nervous Systems)
CNS & Neurological Disorders - Drug Targets Plant Secondary Metabolites- Potent Inhibitors of Monoamine Oxidase Isoforms
Central Nervous System Agents in Medicinal Chemistry The Immunocompromised Host: Immune Alterations in Splenectomized Patients and Clinical Implications
Current Pharmaceutical Design The Pursuit of Differentiated Ligands for the Glucocorticoid Receptor
Current Topics in Medicinal Chemistry Decrease in Secondary Neck Vessels in Multiple Sclerosis: A 5-year Longitudinal Magnetic Resonance Angiography Study
Current Neurovascular Research Mutagenesis in Mice Modern Times
Current Genomics Expanding the Therapeutic Potential of Statins by Means of Nanotechnology Enabled Drug Delivery Systems
Current Topics in Medicinal Chemistry Tyrosine Kinase Inhibitor as a new Therapy for Ischemic Stroke and other Neurologic Diseases: is there any Hope for a Better Outcome?
Current Neuropharmacology Pharmacotherapy and Prevention of Vascular Dementia
CNS & Neurological Disorders - Drug Targets G Protein-Coupled Receptors: Target-Based In Silico Screening
Current Pharmaceutical Design